● Recruiting

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

Condition: Staphylococcus Aureus · Sponsor: AstraZeneca

PhasePhase 1/Phase 2

Planned participants231

Who can joinAll sexes, 18 Years to 55 Years

Healthy volunteersYes

About this study

The purpose of this study is to evaluate the safety and pharmacokinetics (PK) of AZD7760 when given as an intravenous infusion to healthy participants (Phase I) or participants with end-stage kidney disease receiving hemodialysis through a central venous catheter (Phase IIa).

This description comes directly from the study's public registry record.

Talk to the study team

AstraZeneca Clinical Study Information Center · 1-877-240-9479 · information.center@astrazeneca.com

Always discuss trial participation with your own doctor first.

Locations (43)

Research Site	Huntsville, Alabama, United States	Recruiting
Research Site	Chula Vista, California, United States	Withdrawn
Research Site	Chula Vista, California, United States	Recruiting
Research Site	Glendale, California, United States	Recruiting
Research Site	Granada Hills, California, United States	Recruiting
Research Site	Los Angeles, California, United States	Recruiting
Research Site	Northridge, California, United States	Recruiting
Research Site	Northridge, California, United States	Recruiting
Research Site	Oxnard, California, United States	Recruiting
Research Site	Riverside, California, United States	Recruiting
Research Site	San Dimas, California, United States	Recruiting
Research Site	Tarzana, California, United States	Recruiting

+ 31 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06749457